A New MHC Class I & II Deficient Platform Humanized With PBMC Has Delayed Xenogeneic GvHD

GvHD Studies Graft vs Host Disease

$0.47 - $7.00

Select Options

MS-EAE Efficacy Studies

$0.47 - $7.00

Select Options

A New Way to Study Cytokine Release Syndrome

$0.86 - $8.00

Select Options

Preclinical Drug Development

$0.27 - $2.00

Select Options

In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety

$0.47 - $7.00

Select Options

Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

$0.81 - $9.00

Select Options

Lupus Efficacy Studies

$0.47 - $7.00

Select Options

Humanized Mouse Models

$0.34 - $3.00

Select Options